Fareva and ApiJect Systems signed a 10-year licensing agreement to install three Blow-Fill-Seal production lines in France, with Fareva investing over €50 million. The lines will be able to fill-finish more than 500 million doses per year of vaccines and injectable drugs, starting in H2 2022.
Fareva agreed to acquire BCM Cosmétique, a cosmetics manufacturing subsidiary of Walgreens Boots Alliance, and signed a 10-year production contract. BCM Cosmétique has operations in France, Germany and the UK, with €250 million revenue and 2,000 employees.
Excelvision, a subsidiary of Fareva, inaugurated a 4,000 m² extension of its Annonay site, involving a €28 million investment. The new building includes two BFS (Blow, Fill, Seal) lines for aseptic eye drop production, increasing total capacity to 800 million doses and 40 million bottles, and creating about 100 jobs.
Excelvision (groupe Fareva) inaugurated a new eye drop production unit in Annonay, France, after a €28 million investment. The facility has a capacity of one billion doses per year and will create about 100 jobs.